Key result
Embolic protection devices during TAVI may reduce the volume of silent ischemic lesions, but very low quality evidence shows no significant difference in clinical stroke or mortality.
Why the study?
Does the use of embolic protection devices (EPD) reduce silent ischemic and clinically evident cerebrovascular events in patients undergoing TAVI?
Meta-Analysis
Does the use of embolic protection devices (EPD) reduce silent ischemic and clinically evident cerebrovascular events in patients undergoing TAVI?
Answers are grounded in this paper and cite their sources.
The use of embolic protection devices during TAVI may reduce the volume of silent ischemic lesions but does not appear to significantly reduce clinically evident stroke or mortality based on current low-quality evidence.
BACKGROUND AND PURPOSE: Silent ischemic embolic lesions are common after transcatheter aortic valve implantation (TAVI). The use of embolic protection devices (EPD) may reduce the occurrence of these embolic lesions. Thus, a quantitative overview and credibility assessment of the literature was necessary to draw a robust message about EPD. Therefore, the aim of this meta-analysis was to study whether the use of EPD reduces silent ischemic and clinically evident cerebrovascular events associated with TAVI. METHODS: We conducted a comprehensive search to identify studies that evaluated patients undergoing TAVI with or without EPD. Random-effects meta-analyses were performed to estimate the effect of EPD compared with no-EPD during TAVI using aggregate data. CONCLUSIONS: The use of EPD during TAVI may be associated with smaller volume of silent ischemic lesions and smaller total volume of silent ischemic lesions. However, EPD may not reduce the number of new-single, multiple, or total number of lesions. There was only very low quality of evidence showing no significant differences between patients undergoing TAVI with or without EPD with respect to clinically evident stroke and mortality.
No takes yet. Share an insight, caveat, or question.
Bagur et al. (2017) conducted a meta-analysis in Transcatheter aortic valve implantation (TAVI). Embolic protection devices (EPD) vs. No EPD was evaluated on Silent ischemic and clinically evident cerebrovascular events (p==0.05). Embolic protection devices during TAVI may reduce the volume of silent ischemic lesions, but very low quality evidence shows no significant difference in clinical stroke or mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: